Announced Wed, 29 Jul · 20:23 IST
Novartis India changes hands; ChrysCapital-led group takes control
Cfo ResignedMultiple Ind Directors ResignedKmp ResignedManagement Changes View source PDFExplain this filing
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.4%1-day move
₹1600.00
prior close
₹1610.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-2.4+2.8+1.8+2.3-0.1+0.2-7.3———
Up moveDown movePending
AI summary
Novartis India completed the sale of 1.74 crore equity shares from Novartis AG to a ChrysCapital-led group (WaveRise, ChrysCapital Fund X, Two Infinity Partners). Novartis AG exits as promoter and is reclassified as public. Open offer concluded on July 29, 2026. Six directors resigned, including CFO Shilpa Joshi and Chairperson Christopher Snook. Six new directors appointed.
Likely market impact
Major ownership change. Expect new strategic direction under ChrysCapital-led ownership. Board reconstituted. Short-term volatility possible.